Risk factors
Immucell (ICCC) risk factors
Item 1A of every Immucell Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors36 risks6 new12 dropped19 reworded
Re-Tain® strategy shifted from internal manufacture toward licensing, sale, or partnership after abandoning planned production.
Filed Mar 30, 2026 - FY2024 10-K risk factors42 risks
Re-Tain® commercialization depends on FDA approval, funding, customer adoption, and reliable contract manufacturing.
Filed Mar 28, 2025